Anticoagulation/Thromboembolism
RSSArticles
-
Group Leads Charge Against Venous Thromboembolism
The American Heart Association issues guidance to help prevent a common and costly hospital-acquired condition.
-
Warfarin vs. DOAC for Left Ventricular Thrombi
A large, multicenter, observational study of the relative efficacy of warfarin vs. direct oral anticoagulants (DOACs) for left ventricular thrombi has shown that DOAC use is associated with a higher risk of embolic events than warfarin. Investigators advised caution with off-label use of DOACs.
-
Does Anticoagulant Therapy Affect Outcomes in Left Ventricular Mural Thrombus Patients?
Left ventricular thrombus is an uncommon finding but one associated with a high incidence of all-cause mortality and major adverse cardiac and embolic events. Total regression of left ventricular thrombus on anticoagulant therapy reduced mortality.
-
A Review of Atrial Fibrillation and Current Therapeutic Strategies: Part 2
This two-part series presents a review of the current evidence on atrial fibrillation (AF). The first part included the definition of AF, its classification, risk factors, comorbidities, evaluation, and acute management of newly diagnosed patients. The second part focuses on long-term management, including risk factor modification, rate and rhythm control measures, stroke risk stratification, and anticoagulation management.
-
Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft
The data from this study do not indicate that new-onset postoperative atrial fibrillation should be regarded as having the same risks as primary nonvalvular atrial fibrillation in terms of long-term thromboembolic risk, and that anticoagulation in this group may not be necessary unless the atrial fibrillation is persistent.
-
Utility of the New Cholesterol Guidelines
The American College of Cardiology/American Heart Association (ACC/AHA) released new guidelines for the use of statin drugs to prevent atherosclerotic cardiovascular disease (CVD) in 2013.
-
Indication for ICDs in Arrhythmogenic RV Cardiomyopathy Patients
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an uncommon condition with a wide spectrum of possible clinical presentations. Implantable defibrillators (ICDs) are standard therapy for treating ARVD/C patients who present with sustained ventricular tachycardia (VT) or cardiac arrest. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
New recommendations for HPV vaccine; guidelines for treatment of essential tremor; updates on smoking cessation drugs; and FDA actions. -
Laser Pacemaker Lead Extraction in Octogenarians
In this paper, Rodriguez and his colleagues from the Department of Cardiothoracic Surgery at the University of Miami report their experience with laser-assisted cardiac rhythm device lead extraction in a large group of patients.